跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA AUROVITAS 5 MG CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA AUROVITAS 5 MG CAPSULAS DURAS EFG
Eugia Pharma (Malta) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 22, 2021
Approval ID
2ee06a65d0b03b35
Company
Eugia Pharma (Malta) Limited
Type
Standard
Approval Details
Approval Id
2ee06a65d0b03b35
Drug Cima Aemps Name
LENALIDOMIDA AUROVITAS 5 MG CAPSULAS DURAS EFG
Register Number
86339
Holder Company Name
Eugia Pharma (Malta) Limited
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2021-10-22
Dosage Form
CÁPSULA DURA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Eugia Pharma (Malta) Limited
Active Ingredients
LENALIDOMIDA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 22, 2021
Approval ID
2ee06a65d0b03b35
Type
Standard
Back to CIMA-AEMPS Approvals
LENALIDOMIDA AUROVITAS 5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
